Valeant Ruling May Pave Way For Patent-Based FCA Suits

By Joshua Robbins and Rick Taché · March 5, 2024, 3:26 PM EST

In Silbersher v. Valeant Pharmaceuticals International Inc., a generic-drug maker challenged the validity of Valeant's patent before the Patent Trial and Appeal Board and won, with a finding that Valeant got...

To view the full article, register now.